Commonwealth Equity Services, LLC Collegium Pharmaceutical, Inc Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 5,328 shares of COLL stock, worth $163,622. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,328

Holding current value

$163,622

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$31.4 - $39.07 $167,299 - $208,164	5,328 New	5,328 $206,000
Q1 2024 Apr 29, 2024	BUY	$31.23 - $40.91 $160,928 - $210,809	5,153 New	5,153 $200,000
Q1 2023 May 11, 2023	BUY	$23.0 - $29.88 $405,996 - $527,441	17,652 New	17,652 $423,000
Q4 2020 Feb 11, 2021	SELL	$17.83 - $22.29 $175,215 - $219,043	-9,827 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$15.78 - $20.82 $155,070 - $204,598	9,827 New	9,827 $204,000
Q1 2020 May 11, 2020	SELL	$13.89 - $25.45 $390,684 - $715,832	-28,127 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$10.7 - $22.24 $6,420 - $13,343	600 Added 2.18%	28,127 $578,000
Q1 2019 May 13, 2019	SELL	$13.58 - $18.72 $7,591 - $10,464	-559 Reduced 1.99%	27,527 $416,000
Q4 2018 Feb 11, 2019	SELL	$14.78 - $19.68 $11,085 - $14,760	-750 Reduced 2.6%	28,086 $482,000
Q3 2018 Nov 06, 2018	SELL	$14.16 - $24.3 $9,954 - $17,082	-703 Reduced 2.38%	28,836 $425,000
Q2 2018 Jul 31, 2018	BUY	$21.79 - $28.29 $122,895 - $159,555	5,640 Added 23.6%	29,539 $705,000
Q1 2018 May 14, 2018	SELL	$18.15 - $29.21 $29,965 - $48,225	-1,651 Reduced 6.46%	23,899 $610,000
Q4 2017 Feb 12, 2018	BUY	$9.3 - $19.14 $237,615 - $489,027	25,550	25,550 $472,000

Others Institutions Holding COLL

# of Institutions

256

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.05B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Collegium Pharmaceutical, Inc Transaction History